BofA raised the firm’s price target on Alignment Healthcare (ALHC) to $13 from $11 and keeps a Buy rating on the shares after outperformance in Q3 on revenue growth, SG&A leverage, and absolute profit ...
TD Cowen analyst Gary Taylor raised the firm’s price target on Alignment Healthcare (ALHC) to $18.50 from $17 and keeps a Buy rating on the shares. The firm updated its model following Q3 results as ...
In recent trading, shares of Alignment Healthcare Inc (Symbol: ALHC) have crossed above the average analyst 12-month target price of $16.41, changing hands for $16.74/share. When a stock reaches the ...
Barclays raised the firm’s price target on Alignment Healthcare (ALHC) to $18 from $13 and keeps an Equal Weight rating on the shares. The firm updated the company’s model following the earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback